Ampersand Capital Partners has announced the closing of a new fund.
The fund, Ampersand 2026 Limited Partnership, is Ampersand’s twelfth primary fund since 1992. It closed with $1.5 billion in limited partner commitments and was oversubscribed.
Ampersand, founded in 1988 and based in Wellesley, Massachusetts, is a middle market private equity firm with a focus on growth equity investments in the healthcare sector within North America, Europe and the Asia–Pacific region. The firm typically pursues majority or minority positions in companies generating between $10 million and $200 million in revenue and positive EBITDA.